-
-
ADMELOG SOLOSTAR (Brand for INSULIN LISPRO KWIKPEN U-100)
- QTY 15
- 100/ML
- INSULN PEN
- Near 77381
INSULIN LISPRO (IN su lin LYE sproe) treats diabetes. It works by increasing insulin levels in your body, which decreases your blood sugar (glucose). It belongs to a group of medications called rapid-acting insulins. Changes to diet and exercise are often combined with this medication.
Change Location
Set Price Drop Alert for:
ADMELOG SOLOSTAR (Brand for INSULIN LISPRO KWIKPEN U-100)
- QTY 15
- 100/ML
- INSULN PEN
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
ADMELOG SOLOSTAR (Brand for INSULIN LISPRO KWIKPEN U-100)
- QTY 15
- 100/ML
- INSULN PEN
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Generic Available
Medicine Chest
ADMELOG SOLOSTAR (Brand for INSULIN LISPRO KWIKPEN U-100) Lifestyle Interactions
-
Almotriptan Malate 12.5mg, Oral tablet
• Interaction: Grapefruit juice• Severity: Major• Notes for Consumers: Avoid grapefruit juice while taking Almotriptan. Side effects from Almotriptan may get worse if you take these agents together. Taking these drugs together could result in serious side effects such as chest pain, chest tightness or pressure, confusion, dizziness, drowsiness, excessive dry mouth, excessive nausea/vomiting, fever, loss of coordination, muscle twitching or weakness, sweating, tremor, and/or palpitations. Report any of these effects immediately should they occur.• Notes for Professionals: Avoid grapefruit and grapefruit juice while taking almotriptan, as coadministration may increase the systemic exposure of almotriptan. If coadministered, the recommended starting dose of almotriptan is 6.25 mg; do not exceed 12.5 mg within a 24-hour period. Avoid coadministration in patients with renal or hepatic impairment. Almotriptan is a CYP3A4 substrate and grapefruit is a potent CYP3A4 inhibitor. In a drug interaction study, coadministration of almotriptan and ketoconazole, another potent CYP3A4 inhibitor, resulted in an approximately 60% increase in almotriptan exposure.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
